Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,989 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Translating the observed differences in interleukin-6 levels between some antiretroviral regimens into potential long-term risk of serious non-AIDS events: A modeling study.
Serrano-Villar S, Cohen C, Baker JV, Janeiro MJ, Aragão F, Melbourne K, Gonzalez JL, Lara L, Kim C, Moreno S. Serrano-Villar S, et al. Among authors: moreno s. Front Immunol. 2022 Nov 8;13:976564. doi: 10.3389/fimmu.2022.976564. eCollection 2022. Front Immunol. 2022. PMID: 36426353 Free PMC article.
Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study.
Serrano-Villar S, Martínez-Sanz J, Ron R, Talavera-Rodríguez A, Fernández-Felix BM, Herrera S, Muriel A, Fanjul F, Portilla J, Muñoz J, Amador C, de Zárraga MA, Vivancos MJ, Moreno S; Spanish HIV Research Network (CoRIS). Serrano-Villar S, et al. Among authors: moreno s. Lancet HIV. 2020 Aug;7(8):e565-e573. doi: 10.1016/S2352-3018(20)30202-2. Lancet HIV. 2020. PMID: 32763219 Clinical Trial.
Multi-omics in HIV: searching insights to understand immunological non-response in PLHIV.
Espineira S, Flores-Piñas M, Chafino S, Viladés C, Negredo E, Fernández-Arroyo S, Mallolas J, Villar B, Moreno S, Vidal F, Rull A, Peraire J. Espineira S, et al. Among authors: moreno s. Front Immunol. 2023 Aug 15;14:1228795. doi: 10.3389/fimmu.2023.1228795. eCollection 2023. Front Immunol. 2023. PMID: 37649488 Free PMC article. Review.
IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors.
Álvarez H, Gutiérrez-Valencia A, Mariño A, Saborido-Alconchel A, Calderón-Cruz B, Pérez-González A, Alonso-Domínguez J, Martínez-Barros I, Gallego-Rodríguez M, Moreno S, Aldamiz T, Montero-Alonso M, Bernal E, Galera C, Llibre JM, Poveda E. Álvarez H, et al. Among authors: moreno s. Front Immunol. 2023 Oct 18;14:1257725. doi: 10.3389/fimmu.2023.1257725. eCollection 2023. Front Immunol. 2023. PMID: 37920466 Free PMC article.
Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection.
Lodi S, Fisher M, Phillips A, De Luca A, Ghosn J, Malyuta R, Zangerle R, Moreno S, Vanhems P, Boufassa F, Guiguet M, Porter K; CASCADE Collaboration in EuroCoord. Lodi S, et al. Among authors: moreno s. PLoS One. 2013 Nov 14;8(11):e78642. doi: 10.1371/journal.pone.0078642. eCollection 2013. PLoS One. 2013. PMID: 24244330 Free PMC article. Clinical Trial.
Redefining therapeutic success in HIV patients: an expert view.
Antela A, Rivero A, Llibre JM, Moreno S; RET Group. Antela A, et al. Among authors: moreno s. J Antimicrob Chemother. 2021 Sep 15;76(10):2501-2518. doi: 10.1093/jac/dkab168. J Antimicrob Chemother. 2021. PMID: 34077524 Free PMC article. Review.
COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study.
Díez C, Del Romero-Raposo J, Mican R, López JC, Blanco JR, Calzado S, Samperiz G, Portilla J, García-Fraile LJ, Gutiérrez F, Gómez-Sirvent JL, Suárez-García I, Amador C, Novella M, Arribas JR, Moreno S, González-García J, Jarrín I, Berenguer J; for CoRIS. Díez C, et al. Among authors: moreno s. HIV Med. 2021 Oct;22(9):867-876. doi: 10.1111/hiv.13145. Epub 2021 Jul 29. HIV Med. 2021. PMID: 34324783 Free PMC article.
1,989 results